NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Wellington Partners

Wellington Partners

Overview

Wellington Partners is a pan-European venture capital firm that invests in early- and growth-stage life science companies across biotechnology, therapeutics, medical devices, diagnostics, and digital health.

Year Founded

1998

Portfolio Companies

53

Investments

Wellington Partners investments
CompanyDateStageLead
Beren TherapeuticsJun 2026Early FundingCo-investor
NUCLIDIUM AGMay 2026Series B ExtensionLead
nyra healthFeb 2026Series ACo-investor
SNIPR BiomeAug 2025Series BLead
NUCLIDIUM AGJul 2025Series BLead

Key People

Rainer Strohmenger

Managing Partner

Christian Reitberger

General Partner

Stuart Essig

Venture Partner

Wolfgang Baiker

Venture Partner

Johannes Fischer

Partner

Sabine Kannegiesser

Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersMunich
Year Founded1998

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.